LIN9 Antikörper (N-Term)
Kurzübersicht für LIN9 Antikörper (N-Term) (ABIN2784349)
Target
Alle LIN9 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Sequenz
- TRKLTRVEWG KIRRLMGKPR RCSSAFFEEE RSALKQKRQK IRLLQQRKVA
-
Homologie
- Cow: 100%, Dog: 100%, Guinea Pig: 100%, Horse: 100%, Human: 100%, Mouse: 100%, Rabbit: 100%, Rat: 100%, Zebrafish: 86%
-
Produktmerkmale
- This is a rabbit polyclonal antibody against LIN9. It was validated on Western Blot using a cell lysate as a positive control.
-
Aufreinigung
- Affinity Purified
-
Immunogen
- The immunogen is a synthetic peptide directed towards the N terminal region of human LIN9
-
-
-
-
Applikationshinweise
- Optimal working dilutions should be determined experimentally by the investigator.
-
Kommentare
-
Antigen size: 490 AA
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
- LIN9 (Lin-9 Homolog (LIN9))
-
Andere Bezeichnung
- LIN9
-
Hintergrund
-
LIN9 belongs to the lin-9 family and acts as a tumor suppressor. It inhibits DNA synthesis. Its ability to inhibit oncogenic transformation is mediated through its association with RB1. LIN9 plays a role in the expression of genes required for the G1/S transition.
Alias Symbols: TGS, BARA, TGS1, Lin-9, BARPsv
Protein Interaction Partner: MYBL2, E2F4, RBL2, LIN54, LIN52, LIN37, RBL1, RBBP4, UBC, LIN9, TFDP2, TFDP1, MYBL1, RB1,
Protein Size: 490 -
Molekulargewicht
- 53 kDa
-
Gen-ID
- 286826
-
NCBI Accession
- NM_001270409
-
UniProt
- B1B046
-
Pathways
- Zellzyklus, Mitotic G1-G1/S Phases
Target
-